[go: up one dir, main page]

PE20050688A1 - Composiciones hipocolesterolemiantes - Google Patents

Composiciones hipocolesterolemiantes

Info

Publication number
PE20050688A1
PE20050688A1 PE2005000100A PE2005000100A PE20050688A1 PE 20050688 A1 PE20050688 A1 PE 20050688A1 PE 2005000100 A PE2005000100 A PE 2005000100A PE 2005000100 A PE2005000100 A PE 2005000100A PE 20050688 A1 PE20050688 A1 PE 20050688A1
Authority
PE
Peru
Prior art keywords
hypocholesterolemian
compositions
tablets
antiflatulent
composition
Prior art date
Application number
PE2005000100A
Other languages
English (en)
Inventor
Martinez Marta Gerrero
Reig Anna Orriols
Antonio Guglietta
Carreno Manuel M Raga
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of PE20050688A1 publication Critical patent/PE20050688A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COM'PRENDE UNA ESTATINA TAL COMO ATORVASTATINA, CERIVASTATINA, FLUVASTATINA, LOVASTATINA, PITAVASTATINA, ROSUVASTATINA, SIMVASTATINA Y UN AGENTE ANTIFLATULENTO COMO SIMETICONA Y DIMETICONA. DICHA COMPOSICION SE PREPARA BAJO LA FORMA DE COMPRIMIDOS, CAPSULAS, COMPRIMIDOS, JARABE, POLVO, ENTRE OTRAS; CON ACCION ANTIFLATULENTA E HIPOCOLESTEROLEMIANTE
PE2005000100A 2004-02-03 2005-01-27 Composiciones hipocolesterolemiantes PE20050688A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04002317A EP1563837A1 (en) 2004-02-03 2004-02-03 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent

Publications (1)

Publication Number Publication Date
PE20050688A1 true PE20050688A1 (es) 2005-10-14

Family

ID=34684647

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000100A PE20050688A1 (es) 2004-02-03 2005-01-27 Composiciones hipocolesterolemiantes

Country Status (15)

Country Link
US (1) US20080206328A1 (es)
EP (2) EP1563837A1 (es)
JP (1) JP2007520514A (es)
KR (1) KR100815713B1 (es)
CN (1) CN101094667A (es)
AR (1) AR048668A1 (es)
AU (1) AU2005210117A1 (es)
BR (1) BRPI0507420A (es)
CA (1) CA2556181A1 (es)
NO (1) NO20063867L (es)
PA (1) PA8622701A1 (es)
PE (1) PE20050688A1 (es)
TW (1) TW200529818A (es)
UY (1) UY28729A1 (es)
WO (1) WO2005074915A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1006879B (el) * 2005-09-14 2010-07-13 "Φαρματεν" Φαρμακευτικη Βιομηχανικη Εμπορικη Α.Ε., Βελτιωμενες φαρμακευτικες συνθεσεις που περιεχουν αναστολεις της αναγωγασης του 3-υδροξυ-3-μεθυλογλουταρυλοσυνενζυμου α (hmg-coa) και μεθοδος παρασκευης αυτων
PT2018153E (pt) 2006-04-26 2012-07-04 Rosemont Pharmaceuticals Ltd Composições orais líquidas
PT1928425E (pt) * 2006-05-12 2013-04-11 Pharmathen Sa Formulação farmacêutica contendo um inibidor de hmg-coa redutase e método para a preparação deste
CN101229187B (zh) * 2007-01-23 2011-09-28 德国柏林化学股份有限公司 西甲硅油乳剂及其制备方法
JP2015515498A (ja) * 2012-04-30 2015-05-28 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 新規製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444764A (en) * 1979-08-06 1984-04-24 The Dow Chemical Company Phosphorus esters of alkylcycloalkyl-5-pyrimidinols and control of corn rootworm and western spotted cucumber beetle with them
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
DE3322770C2 (de) * 1983-06-24 1985-10-03 Deutsche Gesellschaft für Wiederaufarbeitung von Kernbrennstoffen mbH, 3000 Hannover Vorrichtung zur Handhabung und zum Schutz von Lagergebinden für radioaktive Stoffe
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5177080A (en) * 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
AU7218294A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-alginate combinations
RU2275909C2 (ru) * 2000-07-27 2006-05-10 Плас Кемиклс Б.В. Способы получения симвастатина высокой степени очистки и полусинтетических статинов
ES2284646T3 (es) * 2001-02-22 2007-11-16 Jagotec Ag Combinaciones de estatina-fibrato con efectos secundarios en ayunas-alimentado reducidos.
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
MXPA04006780A (es) * 2002-01-11 2005-06-08 Athpharma Ltd Formulaciones farmaceuticas de pravastatina y metodos para usarlas.
DE10209979A1 (de) * 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
CA2379887C (en) * 2002-04-09 2004-01-20 Bernard Charles Sherman Stable tablets comprising simvastatin
EP1545503A4 (en) * 2002-09-03 2007-12-12 Circ Pharma Res And Dev Ltd PHARMACEUTICAL FORMULATIONS AND METHODS FOR MODIFIED RELEASE OF STATINES

Also Published As

Publication number Publication date
KR100815713B1 (ko) 2008-03-20
KR20060118579A (ko) 2006-11-23
WO2005074915A1 (en) 2005-08-18
BRPI0507420A (pt) 2007-06-26
EP1713469A1 (en) 2006-10-25
US20080206328A1 (en) 2008-08-28
AU2005210117A1 (en) 2005-08-18
UY28729A1 (es) 2005-03-31
JP2007520514A (ja) 2007-07-26
AR048668A1 (es) 2006-05-17
PA8622701A1 (es) 2005-08-10
EP1563837A1 (en) 2005-08-17
NO20063867L (no) 2006-10-26
TW200529818A (en) 2005-09-16
CN101094667A (zh) 2007-12-26
CA2556181A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
BRPI0606883A2 (pt) composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única
WO2005034908A3 (en) A solid dosage form comprising a fibrate and a statin
MX2009003920A (es) Estatina y acidos grasos omega 3 para reducir los niveles de apo b.
MX2007001553A (es) Nuevas composiciones farmaceuticas de estatina y metodos de tratamiento relacionados.
PE106999A1 (es) Composicion de amlodipina y una estatina
BR9908690A (pt) Composição farmacêutica contendo estatina e aspirina
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
PE20080523A1 (es) Composiciones farmaceuticas topicas que comprenden un modificador de respuesta inmune
ATE488225T1 (de) Kaubare, lutschbare und verschluckbare tablette mit einer calciumhaltigen verbindung als wirkstoff
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
AR035875A1 (es) Composicion farmaceutica estable de inhibidores de reductasa hmg-coa, y una tableta para la administracion oral
RU2019112148A (ru) Фармацевтическая композиция и способ лечения неалкогольной жировой болезни печени
PE20050688A1 (es) Composiciones hipocolesterolemiantes
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
EA200701923A1 (ru) Лекарственная форма для перорального введения витамина
TNSN07203A1 (en) Pharmaceutical compositions for the treatment of cellulite
IL174536A (en) Combination comprising candesartan and rosuvastatin, pharmaceutical compositions comprising such combination and use of such combination as a medicament for the prevention or treatment of atherosclerosis or cardiovascular events
AR051950A1 (es) Comprimido multicapa con capas que se separan
ATE400256T1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
MXPA04004907A (es) Composiciones de acetaminofen.
RU2007148908A (ru) Составы для снижения риска возникновения вызванной лекарственными средствами аритмии
FR2817257B1 (fr) Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
GR20050100466A (el) Βελτιωμενες φαρμακευτικες συνθεσεις που περιεχουναναστολεις της αναγωγασης του 3-υδροξυ-3-μεθυλογλουταρυλοσυνενζυμου α (hmg-coa) και μεθοδος παρασκευης αυτων
WO2005058310A3 (en) Use of stating for the treatment of metabolic syndrome

Legal Events

Date Code Title Description
FC Refusal